Press Releases

CHARLOTTESVILLE, Va. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cavion, Inc., a clinical stage biotechnology company developing novel therapeutics for neurological diseases, announced today that their first-in-class T-type calcium channel modulator CX-8998 significantly suppressed seizures in two translational animal models of absence epilepsy. CX-8998 was more effective than the commonly prescribed anti-epilept

GRAND PRAIRIE, Texas--(BUSINESS WIRE)-- Amerigroup is committed to increasing consumer access to high-quality, affordable healthcare. As part of this commitment, Amerigroup and CareMore Health (CareMore) announced today that Amerigroup has added CareMore to its preferred list of care providers for all its Medicare Advantage plans. Starting January 1, 2019, CareMore’s care providers will be available in-ne

GAINESVILLE, Ga.--(BUSINESS WIRE)-- Recro Gainesville has added a 24,000-s

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Generation Bio, a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit, t

ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that i

SALT LAKE CITY--(BUSINESS WIRE)-- Collective Medical, delivering the nation’s most effective network for care collaboration, today announced the appointmen

ISELIN, N.J.--(BUSINESS WIRE)-- Amerigroup is committed to offering Medicare Advantage plans that provide high-quality medical care while also addressing other social and support needs that can impact good health. As part of this commitment, Amerigroup is expanding its 2019 Medicare Advantage offerings with the addition of Everyday Extras, a new package of benefits that provides wellness services including heal

BOSTON--(BUSINESS WIRE)-- Flex Pharma, Inc. (NASDAQ: FLKS), today announced its financial results for the three months ended September 30, 2018. On

HOUSTON--(BUSINESS WIRE)-- DXP Enterprises, Inc. (NASDAQ: DXPE) today announced financial results for the third quarter ended September 30, 2018. The following are results for the three months and nine months ended September 30, 2018, compared to the three months and nine months ended September 30, 2017. A reconciliation of the non-GAAP financial measures can be found in the back of this p

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on November 1, 2018, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 15,400 shares of its common stock to

HUNT VALLEY, Md.--(BUSINESS WIRE)-- Omega Healthcare Investors, Inc. (NYSE:OHI) (the “Company” or “Omega”) today announced its results of operations for the three-month period ended September 30, 2018. The Company reported for the three-month period ended September 30, 2018 net income of $59.1 million or $0.28 per common share. The Company also reported Funds From Operations (“FFO”)

SANTA ANA, Calif.--(BUSINESS WIRE)-- Iteris, Inc. (NASDAQ: ITI), the global leader in applied informatics for transportation and agriculture, and Staphyt Agrosciences, a leading

BEDFORD, Mass.--(BUSINESS WIRE)-- NinePoint Medical, Inc., a transformative medical device company pioneering the use of a real-time imaging platform for gastro

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the third quarter ended September 30, 2018. Third Quarter Financial Results Total revenue grew to $24.7 million for the third quarter 2018 compared to $22.3 mi

IRVING, Texas--(BUSINESS WIRE)-- Vizient, Inc. is disappointed that the Centers for Medicare and Medicaid Services (CMS) opted to finalize site-neutral payment reductions and t